1. Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
   Annamaria Massa et al, 2022, Frontiers in Oncology CrossRef
2. Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma
   Louay Bettaieb et al, 2021, Cancers CrossRef
3. Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
   Angela Ragone et al, 2022, Frontiers in Pharmacology CrossRef
4. MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells
   Francesca Terracciano et al, 2021, Neuroendocrinology CrossRef
5. Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
   Futa Koga et al, 2022, Journal of Geriatric Oncology CrossRef
6. Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis
   Xingzhen Cheng et al, 2022, Canadian Journal of Gastroenterology and Hepatology CrossRef